Posted in Regulatory FDA approves Regeneron’s hearing loss gene therapy April 23, 2026 BioPharma Dive Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA s national priority voucher program and will be offered to eligible patients at n RegulatoryGene TherapyRead full story